NutriBand (NTRB) Assets Growth (1y) (2017 - 2026)
NutriBand (NTRB) Assets Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 12.03% |
| Jan 31, 2026 | 1.04% |
| Oct 31, 2025 | -32.88% |
| Jul 31, 2025 | -25.36% |
| Apr 30, 2025 | -59.40% |
| Jan 31, 2025 | -0.63% |
| Oct 31, 2024 | 47.17% |
| Jul 31, 2024 | 38.10% |
| Apr 30, 2024 | 74.68% |
| Jan 31, 2024 | -20.51% |
| Oct 31, 2023 | -20.12% |
| Jul 31, 2023 | -13.30% |
| Apr 30, 2023 | -27.61% |
| Jan 31, 2023 | -25.77% |
| Oct 31, 2022 | -30.84% |
| Jul 31, 2022 | 12.04% |
| Apr 30, 2022 | 13.49% |
| Jan 31, 2022 | 28.33% |
| Oct 31, 2021 | 53.06% |
| Jul 31, 2021 | 362.13% |